SCHEMBL4551977

SCHEMBL4551977

COC(=O)c1ccc(CCCN2C(=O)OCCC2CO[Si](C)(C)C(C)(C)C)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH1 P35367 2/20 0.42
▸ CYP4A11 Q02928 2/20 0.40
▸ CYP4F2 P78329 1/20 0.39
▸ EP300 Q09472 5/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ IDH1 O75874 1/20 0.34
▸ CHRNB2 P17787 1/20 0.34
▸ CHRNB4 P30926 1/20 0.34
▸ CHRNA3 P32297 1/20 0.34
▸ CHRNA4 P43681 1/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4300107 1.00 HRH1 (0.42) HRH1CYP4A11CYP4F2EP300PTGS1
SCHEMBL4301619 0.84 CYP4F2 (0.41) CYP4A11CYP4F2ALDH1A1HPGD
SCHEMBL4305398 0.83 FKBP1A (0.33) RXFP1ALDH1A1HPGDALOX15HSD17B10
SCHEMBL13663147 0.78 TP53 (0.32) TP53CYP1A2
SCHEMBL13871611 0.77 KDM4E (0.31) ALDH1A1HPGDHSD17B10
SCHEMBL4106475 0.76 PTGER4 (0.34) —
SCHEMBL15551397 0.75 PTGER4 (0.40) HRH1CYP4A11CYP4F2IDH1ALDH1A1
SCHEMBL22159604 0.75 PTGER4 (0.40) HRH1CYP4A11CYP4F2IDH1ALDH1A1
SCHEMBL15551396 0.75 PTGER4 (0.40) HRH1CYP4A11CYP4F2IDH1ALDH1A1
SCHEMBL2211707 0.72 ALDH1A1 (0.39) ALDH1A1ALOX15HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912957-A4 EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS THEREOF MERCK FROSST CANADA LTD (CA) 2009-05-13 — — EP disclosed
EP-1912957-A1 EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS THEREOF Merck Frosst Canada Ltd. (CA) 2008-04-23 — — EP disclosed
WO-2007014462-A1 EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS THEREOF MERCK FROSST CANADA LTD. (CA) 2007-02-08 — — WO disclosed
Send feedback